Louis Edward Tamayo - 15 Aug 2025 Form 3 Insider Report for Lexeo Therapeutics, Inc. (LXEO)

Role
Chief Financial Officer
Signature
/s/ Youjin Choi, Attorney-in-Fact
Issuer symbol
LXEO
Transactions as of
15 Aug 2025
Net transactions value
$0
Form type
3
Filing time
27 Aug 2025, 18:51:31 UTC
Next filing
03 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tamayo Louis Edward Chief Financial Officer C/O LEXEO THERAPEUTICS, INC., 345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK /s/ Youjin Choi, Attorney-in-Fact 27 Aug 2025 0002083206

No securities are beneficially owned.